Australian Crohn’s Antibiotic Study Opens New Horizons

References 

1. Selby W, Pavli P, Crotty B, et al. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn’s disease. Gastroenterology. 2007;132:2313–2319
   • Abstract
   • Full Text
   • Full-Text PDF (223 KB)
   • CrossRef
2. ICH Harmonised Tripartite Guideline: General Considerations for Clinical Trials E8.
3. Sandborn WJ, Feagan BG, Hanauer SB, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn’s disease. Gastroenterology. 2002;122:512–530
   • Abstract
   • Full Text
   • Full-Text PDF (233 KB)
   • CrossRef
4. Continuing medical education exam 2. Gastroenterology. 2007;132:2578–2579
   • Full-Text PDF (47 KB)
   • CrossRef
5. Greenstein RJ. Is Crohn’s disease caused by a mycobacterium? (Comparisons with leprosy, tuberculosis, and Johne’s disease). Lancet. 2003;3:507–514
6. Borody TJ, Heifets LB. Severe recurrent Crohn’s disease of ileocolonic anastomosis and antimicrobial (anti-mycobacterial) therapy. Gut. 2006;55:1211
   • MEDLINE
7. Chamberlin W, Ghobrial G, Chehtane M, et al. Successful treatment of a Crohn’s disease patient infected with bacteremic Mycobacterium paratuberculosis. Am J Gastroenterol. 2006;102:689–691
   • MEDLINE
   • CrossRef
8. Borody TJ, Bilkey S, Wettstein AR, et al. Anti-mycobacterial therapy in Crohn’s disease heals mucosa with longitudinal scars. Dig Liver Dis. 2007;39:438–444
   • Abstract
   • Full Text
   • Full-Text PDF (1683 KB)
   • CrossRef